Carsten P. Ade
Impact in
- Cancer Research top 10%
- Cancer, Hypoxia, and Metabolism
- Oncology top 10%
- Lung Cancer Research Studies
- Cancer-related Molecular Pathways
Papers in
-
- RNA Research and Splicing 8
- Ubiquitin and proteasome pathways 8
- Protein Degradation and Inhibitors 5
- RNA modifications and cancer 5
- Genomics and Chromatin Dynamics 4
- Epigenetics and DNA Methylation 3
- Oncology 8
- Cancer-related Molecular Pathways 4
- Co-authors
- Martin Eilers (20 shared papers)Susanne Walz (10 shared papers)Elmar Wolf (13 shared papers)Apoorva Baluapuri (11 shared papers)Werner Schmitz (6 shared papers)Christina Schülein‐Völk (9 shared papers)Susanne Kneitz (5 shared papers)Owen J. Sansom (2 shared papers)
- Journals
- Molecular Cell (4 papers)Oncogene (4 papers)Genes & Development (3 papers)EMBO Molecular Medicine (2 papers)The EMBO Journal (2 papers)
- Partner nations
- GermanyUnited KingdomNetherlands
In The Last Decade
Carsten P. Ade
33 papers receiving 1000 citations
Peers
Comparison fields: 5 of 78
- Cancer Research 193
- Oncology 321
- Molecular Biology 708
- Cell Biology 119
- Biochemistry 34
Countries citing papers authored by Carsten P. Ade
This map shows the geographic impact of Carsten P. Ade's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carsten P. Ade with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carsten P. Ade more than expected).
Fields of papers citing papers by Carsten P. Ade
This network shows the impact of papers produced by Carsten P. Ade. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carsten P. Ade. The network helps show where Carsten P. Ade may publish in the future.
Co-authors
The 25 scholars most cited alongside Carsten P. Ade, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 35 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 141 | |
| 2 | 2014 | 92 | |
| 3 | 2016 | 81 | |
| 4 | 2019 | 68 | |
| 5 | 2019 | 66 | |
| 6 | 2020 | 60 | |
| 7 | 2017 | 52 | |
| 8 | 2019 | 52 | |
| 9 | 2020 | 47 | |
| 10 | 2020 | 43 | |
| 11 | 2020 | 40 | |
| 12 | 2018 | 31 | |
| 13 | 2020 | 29 | |
| 14 | 2021 | 27 | |
| 15 | 2020 | 24 | |
| 16 | 2021 | 24 | |
| 17 | 2020 | 23 | |
| 18 | 2021 | 19 | |
| 19 | 2023 | 13 | |
| 20 | 2014 | 11 |
About Carsten P. Ade
Carsten P. Ade is a scholar working on Molecular Biology, Oncology, Cell Biology, Plant Science and Cancer Research, having authored 35 papers that have together received 1.0k indexed citations. Recurring topics across this work include RNA Research and Splicing (8 papers), Ubiquitin and proteasome pathways (8 papers), Protein Degradation and Inhibitors (5 papers), Hippo pathway signaling and YAP/TAZ (5 papers), RNA modifications and cancer (5 papers), Genomics and Chromatin Dynamics (4 papers), Cancer-related Molecular Pathways (4 papers) and Epigenetics and DNA Methylation (3 papers). The work is most often cited by research in Cancer Research (193 citations), Oncology (321 citations), Molecular Biology (708 citations), Cell Biology (119 citations) and Biochemistry (34 citations). Carsten P. Ade has collaborated with scholars based in Germany, United Kingdom and Netherlands. Frequent co-authors include Martin Eilers, Susanne Walz, Elmar Wolf, Apoorva Baluapuri, Werner Schmitz, Christina Schülein‐Völk, Susanne Kneitz, Owen J. Sansom, Steffi Herold and Björn von Eyß. Their work appears in journals such as Molecular Cell, Oncogene, Genes & Development, EMBO Molecular Medicine and The EMBO Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.